Last reviewed · How we verify
Dorzolamide Hcl 2% Oph Soln — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Dorzolamide Hcl 2% Oph Soln (Dorzolamide Hcl 2% Oph Soln) — University of the Incarnate Word.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Dorzolamide Hcl 2% Oph Soln TARGET | Dorzolamide Hcl 2% Oph Soln | University of the Incarnate Word | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Dorzolamide Hcl 2% Oph Soln CI watch — RSS
- Dorzolamide Hcl 2% Oph Soln CI watch — Atom
- Dorzolamide Hcl 2% Oph Soln CI watch — JSON
- Dorzolamide Hcl 2% Oph Soln alone — RSS
Cite this brief
Drug Landscape (2026). Dorzolamide Hcl 2% Oph Soln — Competitive Intelligence Brief. https://druglandscape.com/ci/dorzolamide-hcl-2-oph-soln. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab